Delivery Order SPE2DE24D0013-SPE2D625F8KD5
- Not listed
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- This delivery order, valued at $40,800, was awarded to Cepheid Inc. on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division for the provision of molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by September 2, 2025. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $5,440 to Cepheid Inc. on August 25, 2025, for the supply of COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for completion by September 2, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The award represents a continuation of Cepheid's established role...
- The Defense Logistics Agency's Medical Supply Chain branch awarded a $34,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic manufacturer based in Sunnyvale, California, for 10 tests of a COVID-19/Influenza/RSV diagnostic kit. The contract, issued on May 29, 2025, is scheduled for completion by June 6, 2025, with performance taking place in Sunnyvale. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing support to federal...
- This delivery order, valued at $6,800, was awarded to Cepheid Inc. on September 4, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract covers molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance to be completed at Cepheid's Sunnyvale, California facility by September 11, 2025. The award carries a firm fixed-price structure with no set-aside designation, indicating competitive procurement....
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $14,448 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and will be performed at Cepheid's...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $13,980 to Cepheid Inc. for COVID-19/Influenza/RSV diagnostic test kits on August 8, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents procurement of molecular diagnostic testing solutions from the Sunnyvale, California-based manufacturer. The delivery order will be performed at Cepheid's Sunnyvale facility. This...
- This delivery order, valued at $19,047.16, was awarded to Cepheid Inc. on August 13, 2025, by the Defense Logistics Agency (operating under the Medical Supply Chain program) for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is a firm fixed-price arrangement with no set-aside designation and is scheduled for completion by August 20, 2025. Performance will take place at Cepheid's facility in Sunnyvale, California. Cepheid...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,080 to Cepheid Inc. for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, issued on August 22, 2025, with completion targeted for August 29, 2025, represents a continuation of the Medical Supply Chain's procurement of molecular diagnostic testing capabilities. Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems and...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F8KD5Delivery Order
This delivery order, awarded on July 24, 2025, represents a $17,680 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc. for a COVID-19/Influenza/RSV diagnostic kit containing 10 viral tests. The contract is set to be completed by July 31, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This award is issued without a set-aside designation and falls under Cepheid's existing indefinite delivery vehicle contracts with the Veterans Administration, which provide ongoing access to the company's molecular diagnostic testing solutions across federal healthcare systems. Cepheid, a leading manufacturer of molecular diagnostic systems, has established itself as a key supplier to federal agencies through multiple contract vehicles valued at tens of millions of dollars. The company specializes in GeneXpert diagnostic platforms and associated reagent kits designed to detect infectious diseases, including COVID-19, influenza, RSV, and other pathogens. This particular delivery order reflects the ongoing federal demand for rapid, multiplexed respiratory pathogen testing capabilities within defense and Veterans Affairs medical networks, leveraging Cepheid's established relationships and existing contract infrastructure to fulfill immediate diagnostic testing needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 7/24/25 |